Gerald Wolf, PhD, MD, joined Advanced Magnetics (Cambridge, Massachusetts) as vice president of imaging. Wolf was most recently with Advanced Magnetics as medical director of Perceptive Informatics. He is also an emeritus professor of radiology at Harvard Medical School. Advanced Magnetics is developing its nano-particle technology for use in therapeutic iron compounds to treat anemia, as well as new imaging agents to aid in the diagnosis of cardiovascular disease and cancer.

Jerry Wildman, DDS, has been selected to lead the development and commercialization of BoneGen-TR, a bone augmentation material manufactured by BioLok International (Deerfield Beach, Florida). Previously, Wildman led a dental practice for 15 years before pursuing a career in management in 1997 with Ion Laser Technology. BioLok International is merging cell biology and technology to develop products for the dental implant and tissue regeneration markets.

David Weber has been named CEO, president and director of Eksigent Technologies (Dublin, California), creator of advanced nanofluidic technologies for life science research and medical device applications. Weber joins the company from Stratagene, where he was vice president of global marketing and business development. He also served as president of the Americas at Amersham Biosciences from 2001 to 2004.

Gregory Fisher has been named vice president of sales with Stanbio Laboratory (Boerne, Texas). Previously, Fisher was with Fisher HealthCare, most recently as regional vice president of sales. Stanbio provides laboratories with clinical diagnostic reagents, clinical instruments and a variety of diagnostic products.